151 related articles for article (PubMed ID: 8388971)
1. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders.
Oshimi K; Yamada O; Kaneko T; Nishinarita S; Iizuka Y; Urabe A; Inamori T; Asano S; Takahashi S; Hattori M
Leukemia; 1993 Jun; 7(6):782-8. PubMed ID: 8388971
[TBL] [Abstract][Full Text] [Related]
2. Clinical analysis of 52 patients with granular lymphocyte proliferative disorder (GLPD) showed frequent anemia in indolent T-cell GLPD in Japan.
Kawahara S; Sasaki M; Isobe Y; Ando J; Noguchi M; Koike M; Hirano T; Oshimi K; Sugimoto K
Eur J Haematol; 2009 Apr; 82(4):308-14. PubMed ID: 19220421
[TBL] [Abstract][Full Text] [Related]
3. Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders.
Kobayashi Y; Watanabe N; Oshimi K
Leuk Lymphoma; 1994 Jun; 14(1-2):157-61. PubMed ID: 7920224
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
Nichols GE; Normansell DE; Williams ME
Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
[TBL] [Abstract][Full Text] [Related]
5. [Characterization of peripheral blood natural killer (NK) cells in two patients with CD16+ CD56- NK cell-lineage granular lymphocyte-proliferative disorder].
Egashira M; Kaneko T; Oshimi K; Mizoguchi H; Ishida M
Rinsho Ketsueki; 1995 Feb; 36(2):69-75. PubMed ID: 7536278
[TBL] [Abstract][Full Text] [Related]
6. Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes.
Mitsui T; Maekawa I; Yamane A; Ishikawa T; Koiso H; Yokohama A; Handa H; Matsushima T; Tsukamoto N; Murakami H; Nojima Y; Karasawa M
Br J Haematol; 2004 Jul; 126(1):55-62. PubMed ID: 15198732
[TBL] [Abstract][Full Text] [Related]
7. [NK- and T-cell granular lymphocyte-proliferative disorders].
Sakata T; Amano M; Yamada K; Oshimi K; Kobayashi Y; Togawa A
Rinsho Ketsueki; 1990 Apr; 31(4):462-7. PubMed ID: 2381062
[TBL] [Abstract][Full Text] [Related]
8. T cell receptor delta gene organization and expression in normal and leukemic natural killer cells.
Biondi A; Allavena P; Rossi V; Bassan R; Barbui T; Champagne E; Mak TW; Minden MD; Rambaldi A; Mantovani A
J Immunol; 1989 Aug; 143(3):1009-14. PubMed ID: 2526173
[TBL] [Abstract][Full Text] [Related]
9. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of non-major histocompatibility complex-restricted cytotoxicity in patients with granular lymphocyte-proliferative disorders associated with or unassociated with severe anemia.
Oshimi K; Oshimi Y; Motoji T; Mizoguchi H
Am J Hematol; 1992 Jun; 40(2):93-7. PubMed ID: 1585924
[TBL] [Abstract][Full Text] [Related]
11. The detection of clonal proliferation in granular lymphocyte-proliferative disorders of natural killer cell lineage.
Shimodaira S; Ishida F; Kobayashi H; Mahbub B; Kawa-Ha K; Kitano K
Br J Haematol; 1995 Jul; 90(3):578-84. PubMed ID: 7646997
[TBL] [Abstract][Full Text] [Related]
12. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
13. Analysis of lymphocyte phenotype and T cell receptor genotype in Felty's syndrome.
Meliconi R; Kingsley GH; Pitzalis C; Sakkas L; Panayi GS
J Rheumatol; 1992 Jul; 19(7):1058-64. PubMed ID: 1380988
[TBL] [Abstract][Full Text] [Related]
14. [Reversed C.P.C.: Aggressive NK-cell leukemia/lymphoma].
Koyama T
Rinsho Byori; 2001 Mar; Suppl 115():140-3. PubMed ID: 11391932
[TBL] [Abstract][Full Text] [Related]
15. Gamma/delta T-cell receptor type granular lymphocyte proliferative disorder associated with rheumatoid arthritis.
Zenibayashi M; Saigo K; Chayahara N; Sakamoto Y; Inujima K; Imamura Y; Takada M; Kawano S; Tatsumi E; Kumagai S
J Int Med Res; 2005; 33(5):583-9. PubMed ID: 16222892
[TBL] [Abstract][Full Text] [Related]
16. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
[TBL] [Abstract][Full Text] [Related]
17. Lymphoproliferative disease of granular lymphocytes with T-cell receptor gamma delta-positive phenotype: restricted usage of T-cell receptor gamma and delta subunit genes.
Makishima H; Ishida F; Saito H; Ichikawa N; Ozaki Y; Ito S; Ota M; Katsuyama Y; Kiyosawa K
Eur J Haematol; 2003 Apr; 70(4):212-8. PubMed ID: 12656743
[TBL] [Abstract][Full Text] [Related]
18. CD3(-) large granular lymphocyte leukemia with clonal rearrangement of the gamma and beta genes of the T-cell receptor.
Manteiga R; Florensa L; Solé F; Prat M; Besses C; Woessner S
Haematologica; 2000 Aug; 85(8):879-80. PubMed ID: 10942944
[No Abstract] [Full Text] [Related]
19. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
Robertson MJ; Cochran KJ; Cameron C; Le JM; Tantravahi R; Ritz J
Exp Hematol; 1996 Feb; 24(3):406-15. PubMed ID: 8599969
[TBL] [Abstract][Full Text] [Related]
20. Lymphoproliferative disorder of granular lymphocytes. A heterogeneous disease.
McDaniel HL; MacPherson BR; Tindle BH; Lunde JH
Arch Pathol Lab Med; 1992 Mar; 116(3):242-8. PubMed ID: 1371379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
